A Multi-Site RCT of a Stepped-Care Intervention for Emergency Department Patients With Panic Attacks and Panic Disorder
NCT03632356 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79
Last updated 2023-12-21
Summary
Using a randomized controlled trial (RCT) design, the main objective of this study is to evaluate the clinical, patient-centered, and economic effectiveness of a stepped-care intervention for patients with panic attacks and panic disorder presenting to the busiest Accident and Emergency (A\&E) departments of the largest public healthcare group in Singapore.
The RCT will have two arms: 1) treatment via an enhanced care pathway consisting of a stepped-care intervention for panic attacks and panic disorder; and 2) a control arm consisting of screening for panic attacks and panic disorder in the A\&E and discharge (routine care). In addition to the baseline assessment, the study follow-up visits will occur at 1, 3, 6, and 12 months.
Conditions
- Panic Attacks and Disorders
Interventions
- BEHAVIORAL
-
Stepped Care Intervention (STEP)
A stepwise progression of intervention according to the participant's response to the increasing levels of therapy. There will be 1 session of psychoeducation, followed by 5 sessions of Cognitive Behavioral Therapy (CBT) if panic symptoms do not improve at 1-month follow-up.
- DIAGNOSTIC_TEST
-
Screening only
Screening for probable panic attacks or panic disorder using the Structured Clinical Interview for DSM-5
Sponsors & Collaborators
-
Duke-NUS Graduate Medical School
collaborator OTHER -
Changi General Hospital
collaborator OTHER -
National Medical Research Council (NMRC), Singapore
collaborator OTHER_GOV -
Singapore General Hospital
lead OTHER
Principal Investigators
-
Sharon C Sung, PhD · Duke-NUS Graduate Medical School
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-11
- Primary Completion
- 2024-05-31
- Completion
- 2024-11-30
Countries
- Singapore
Study Locations
More Related Trials
-
Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain
NCT00736346 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder
NCT00705380 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder
NCT05772104 ·Status: RECRUITING ·Phase: PHASE3
-
Experimental Medication For the Treatment of Generalized Anxiety Disorder
NCT00097708 ·Status: COMPLETED ·Phase: PHASE3
-
Interoceptive Exposure in Panic Disorder
NCT06073691 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder
NCT00635531 ·Status: TERMINATED ·Phase: PHASE4
-
Psychopharmacology of Fear-Potentiated Startle in Humans
NCT00044096 ·Status: COMPLETED
-
Dexmedetomidine Nasal Spray for the Treatment of Panic Attacks in Adults
NCT07162649 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder
NCT00108836 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
NCT05970510 ·Status: RECRUITING ·Phase: PHASE3
-
Arousal Training for Social Anxiety Disorder
NCT02493010 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder
NCT05729373 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder
NCT00790868 ·Status: COMPLETED ·Phase: PHASE2
-
Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)
NCT05401565 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Treatment for Panic Disorder
NCT00456768 ·Status: COMPLETED
-
Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome
NCT01475383 ·Status: WITHDRAWN ·Phase: PHASE2
-
Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705)
NCT00725725 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy of Hydroxyzine for Patients With Panic Disorder
NCT05737511 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
D-cycloserine Augmented CBT for Panic Disorder
NCT01680107 ·Status: TERMINATED ·Phase: PHASE3
-
Tailored Internet-administrated Treatment of Panic Symptoms - A Randomised Controlled Trial
NCT01296321 ·Status: UNKNOWN ·Phase: NA
-
ACT-smart: Smartphone-supplemented iCBT for Social Phobia and/or Panic Disorder
NCT01963806 ·Status: COMPLETED ·Phase: NA
-
Personalized Digital Treatment for Adolescent Anxiety: A Feasibility Trial
NCT07145307 ·Status: RECRUITING ·Phase: NA
-
Mobile-assisted Case Management for Panic Disorder
NCT05832905 ·Status: COMPLETED
-
A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder
NCT00635076 ·Status: TERMINATED ·Phase: PHASE4
-
Guanfacine Immediate-release Electrocardiogram Results (QTc) Study
NCT00672984 ·Status: COMPLETED ·Phase: PHASE1